Tong Ren Tang Technologies Co. Ltd
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes of Chinese medicine products in Mainland China and Hong Kong. It operates through The Company and Tong Ren Tang Chinese Medicine segments. The company also offers Chinese medicinal raw materials, ointments, foot care products, healthcare products, biological products, western medicine, cosmetics, tea dri… Read more
Market Cap & Net Worth: Tong Ren Tang Technologies Co. Ltd (TGRNF)
Tong Ren Tang Technologies Co. Ltd (PINK:TGRNF) has a market capitalization of $388.16 Million ($388.16 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #11899 globally and #5217 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tong Ren Tang Technologies Co. Ltd's stock price $0.62 by its total outstanding shares 628704000 (628.70 Million).
Tong Ren Tang Technologies Co. Ltd Market Cap History: 2015 to 2025
Tong Ren Tang Technologies Co. Ltd's market capitalization history from 2015 to 2025. Data shows growth from $880.19 Million to $388.16 Million (0.00% CAGR).
Tong Ren Tang Technologies Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tong Ren Tang Technologies Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Tong Ren Tang Technologies Co. Ltd's market cap is 0.06 times its annual revenue
0.84x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.83x
Tong Ren Tang Technologies Co. Ltd's market cap is 0.83 times its annual earnings
11.15x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $880.19 Million | $4.07 Billion | $540.48 Million | 0.22x | 1.63x |
| 2016 | $751.49 Million | $4.67 Billion | $595.65 Million | 0.16x | 1.26x |
| 2017 | $751.87 Million | $5.03 Billion | $666.67 Million | 0.15x | 1.13x |
| 2018 | $723.83 Million | $5.06 Billion | $677.82 Million | 0.14x | 1.07x |
| 2019 | $535.84 Million | $4.48 Billion | $417.65 Million | 0.12x | 1.28x |
| 2020 | $335.41 Million | $4.61 Billion | $467.55 Million | 0.07x | 0.72x |
| 2021 | $352.45 Million | $5.40 Billion | $507.25 Million | 0.07x | 0.69x |
| 2022 | $413.12 Million | $5.99 Billion | $582.89 Million | 0.07x | 0.71x |
| 2023 | $541.69 Million | $6.77 Billion | $590.19 Million | 0.08x | 0.92x |
| 2024 | $432.74 Million | $7.26 Billion | $521.79 Million | 0.06x | 0.83x |
Competitor Companies of TGRNF by Market Capitalization
Companies near Tong Ren Tang Technologies Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Tong Ren Tang Technologies Co. Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Tong Ren Tang Technologies Co. Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Tong Ren Tang Technologies Co. Ltd's market cap moved from $880.19 Million to $ 388.16 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $388.16 Million | -10.30% |
| 2024 | $432.74 Million | -20.11% |
| 2023 | $541.69 Million | +31.12% |
| 2022 | $413.12 Million | +17.21% |
| 2021 | $352.45 Million | +5.08% |
| 2020 | $335.41 Million | -37.40% |
| 2019 | $535.84 Million | -25.97% |
| 2018 | $723.83 Million | -3.73% |
| 2017 | $751.87 Million | +0.05% |
| 2016 | $751.49 Million | -14.62% |
| 2015 | $880.19 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Tong Ren Tang Technologies Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $388.16 Million USD |
| MoneyControl | $388.16 Million USD |
| MarketWatch | $388.16 Million USD |
| marketcap.company | $388.16 Million USD |
| Reuters | $388.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.